Literature DB >> 21166842

The potential for a two-stage diabetes risk algorithm combining non-laboratory-based scores with subsequent routine non-fasting blood tests: results from prospective studies in older men and women.

S G Wannamethee1, O Papacosta, P H Whincup, M C Thomas, C Carson, D A Lawlor, S Ebrahim, N Sattar.   

Abstract

AIM: To develop strategies based on simple clinical assessment and blood markers to identify older individuals at high risk for Type 2 diabetes.
METHODS: A prospective study of non-diabetic men (n = 3523) and women (n = 3404) aged 60-79 years followed for 7 years, during which there were 297 incident cases of Type 2 diabetes. Logistic regression was used to develop scores to predict incident cases, starting with clinical predictors and adding blood markers that predicted the incidence of diabetes. Receiving operating characteristic analyses were used to assess improvement in prediction.
RESULTS: The area under the curve for a simple clinical assessment score, which included age, sex, family history of diabetes, smoking status, BMI, waist circumference, hypertension and recall of doctor diagnosis of coronary heart disease was 0.765 (0.740, 0.791); sensitivity and specificity in the top quintile of the score were 50.3 and 81.4%, respectively. Addition of simple fasting blood markers HDL cholesterol, triglyceride and glucose improved prediction [area under the curve = 0.817 (0.793, 0.840), P < 0.0001; sensitivity 63.8%; specificity 82.0%]. An alternative model adding blood markers not dependent on fasting yielded similar results. Further addition of C-reactive protein made no improvement. Blood measurements made small differences to reclassification of risk in those in the lowest three quintiles of the non-laboratory score.
CONCLUSION: In large population settings, simple clinical assessments could be used in the first instance to identify older adults who would benefit from further testing with routine (non-fasting) blood markers to identify those at most likely to be at elevated diabetes risk.
© 2010 The Authors. Diabetic Medicine © 2010 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21166842     DOI: 10.1111/j.1464-5491.2010.03171.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  19 in total

1.  HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards.

Authors:  N Sattar; D Preiss
Journal:  Diabetologia       Date:  2012-03-08       Impact factor: 10.122

2.  Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.

Authors:  Ben Schöttker; Elke Raum; Dietrich Rothenbacher; Heiko Müller; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2011-09-27       Impact factor: 8.082

3.  Discriminatory value of alanine aminotransferase for diabetes prediction: the Insulin Resistance Atherosclerosis Study.

Authors:  C Lorenzo; A J Hanley; M J Rewers; S M Haffner
Journal:  Diabet Med       Date:  2015-07-16       Impact factor: 4.359

Review 4.  Revisiting the links between glycaemia, diabetes and cardiovascular disease.

Authors:  N Sattar
Journal:  Diabetologia       Date:  2013-01-27       Impact factor: 10.122

Review 5.  Type 2 Diabetes Prevention: Implications of Hemoglobin A1c Genetics.

Authors:  Aaron Leong; James B Meigs
Journal:  Rev Diabet Stud       Date:  2016-02-10

6.  Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6).

Authors:  Y Heianza; Y Arase; S D Hsieh; K Saito; H Tsuji; S Kodama; S Tanaka; Y Ohashi; H Shimano; N Yamada; S Hara; H Sone
Journal:  Diabetologia       Date:  2012-09-07       Impact factor: 10.122

7.  Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study.

Authors:  Ali Abbasi; Linda M Peelen; Eva Corpeleijn; Yvonne T van der Schouw; Ronald P Stolk; Annemieke M W Spijkerman; Daphne L van der A; Karel G M Moons; Gerjan Navis; Stephan J L Bakker; Joline W J Beulens
Journal:  BMJ       Date:  2012-09-18

Review 8.  Risk models and scores for type 2 diabetes: systematic review.

Authors:  Douglas Noble; Rohini Mathur; Tom Dent; Catherine Meads; Trisha Greenhalgh
Journal:  BMJ       Date:  2011-11-28

9.  Liver function tests and risk prediction of incident type 2 diabetes: evaluation in two independent cohorts.

Authors:  Ali Abbasi; Stephan J L Bakker; Eva Corpeleijn; Daphne L van der A; Ron T Gansevoort; Rijk O B Gans; Linda M Peelen; Yvonne T van der Schouw; Ronald P Stolk; Gerjan Navis; Annemieke M W Spijkerman; Joline W J Beulens
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

10.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.